NEW YORK (GenomeWeb News) – The UK should begin taking steps to prepare for the "potential impact of genomic medicine" on health care, and begin taking steps to ensure that new genomic technologies and knowledge are integrated into the national health system, according to a government committee that has completed a review of the field.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.